Cargando…

CSF sTREM2: marking the tipping point between preclinical AD and dementia?

Biomarkers for Alzheimer's disease (AD) have improved our understanding of the temporal sequence of biological events that lead to AD dementia (Jack et al, 2013). AD is characterized neuropathologically by amyloid plaques comprised of the amyloid‐β peptide and neurofibrillary tangles comprised...

Descripción completa

Detalles Bibliográficos
Autores principales: Schindler, Suzanne E, Holtzman, David M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125351/
https://www.ncbi.nlm.nih.gov/pubmed/26976613
http://dx.doi.org/10.15252/emmm.201606245

Ejemplares similares